Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study
Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hea...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
MD Taher Ahmed Mazumder [verfasserIn] Jyotirmoy Phookan [verfasserIn] Nabajyoti Saikia [verfasserIn] Monikuntal Sarmah [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2023 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Journal of Clinical and Diagnostic Research - JCDR Research and Publications Private Limited, 2009, 17(2023), 1, Seite MC05-MC09 |
|---|---|
| Übergeordnetes Werk: |
volume:17 ; year:2023 ; number:1 ; pages:MC05-MC09 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.7860/JCDR/2023/58318.17210 |
|---|
| Katalog-ID: |
DOAJ081274416 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ081274416 | ||
| 003 | DE-627 | ||
| 005 | 20230310211820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230310s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7860/JCDR/2023/58318.17210 |2 doi | |
| 035 | |a (DE-627)DOAJ081274416 | ||
| 035 | |a (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MD Taher Ahmed Mazumder |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. | ||
| 650 | 4 | |a chemotherapy | |
| 650 | 4 | |a conductive hearing loss | |
| 650 | 4 | |a mixed hearing loss | |
| 650 | 4 | |a sensorineural hearing loss | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Jyotirmoy Phookan |e verfasserin |4 aut | |
| 700 | 0 | |a Nabajyoti Saikia |e verfasserin |4 aut | |
| 700 | 0 | |a Monikuntal Sarmah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Clinical and Diagnostic Research |d JCDR Research and Publications Private Limited, 2009 |g 17(2023), 1, Seite MC05-MC09 |w (DE-627)789478048 |w (DE-600)2775283-5 |x 0973709X |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2023 |g number:1 |g pages:MC05-MC09 |
| 856 | 4 | 0 | |u https://doi.org/10.7860/JCDR/2023/58318.17210 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2249-782X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0973-709X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2055 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2023 |e 1 |h MC05-MC09 | ||
| author_variant |
m t a m mtam j p jp n s ns m s ms |
|---|---|
| matchkey_str |
article:0973709X:2023----::ueoeuimtyidnseoenatraiteaynednnccneptetaoptla |
| hierarchy_sort_str |
2023 |
| publishDate |
2023 |
| allfields |
10.7860/JCDR/2023/58318.17210 doi (DE-627)DOAJ081274416 (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 DE-627 ger DE-627 rakwb eng MD Taher Ahmed Mazumder verfasserin aut Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss Medicine R Jyotirmoy Phookan verfasserin aut Nabajyoti Saikia verfasserin aut Monikuntal Sarmah verfasserin aut In Journal of Clinical and Diagnostic Research JCDR Research and Publications Private Limited, 2009 17(2023), 1, Seite MC05-MC09 (DE-627)789478048 (DE-600)2775283-5 0973709X nnns volume:17 year:2023 number:1 pages:MC05-MC09 https://doi.org/10.7860/JCDR/2023/58318.17210 kostenfrei https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 kostenfrei https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf kostenfrei https://doaj.org/toc/2249-782X Journal toc kostenfrei https://doaj.org/toc/0973-709X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 17 2023 1 MC05-MC09 |
| spelling |
10.7860/JCDR/2023/58318.17210 doi (DE-627)DOAJ081274416 (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 DE-627 ger DE-627 rakwb eng MD Taher Ahmed Mazumder verfasserin aut Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss Medicine R Jyotirmoy Phookan verfasserin aut Nabajyoti Saikia verfasserin aut Monikuntal Sarmah verfasserin aut In Journal of Clinical and Diagnostic Research JCDR Research and Publications Private Limited, 2009 17(2023), 1, Seite MC05-MC09 (DE-627)789478048 (DE-600)2775283-5 0973709X nnns volume:17 year:2023 number:1 pages:MC05-MC09 https://doi.org/10.7860/JCDR/2023/58318.17210 kostenfrei https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 kostenfrei https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf kostenfrei https://doaj.org/toc/2249-782X Journal toc kostenfrei https://doaj.org/toc/0973-709X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 17 2023 1 MC05-MC09 |
| allfields_unstemmed |
10.7860/JCDR/2023/58318.17210 doi (DE-627)DOAJ081274416 (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 DE-627 ger DE-627 rakwb eng MD Taher Ahmed Mazumder verfasserin aut Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss Medicine R Jyotirmoy Phookan verfasserin aut Nabajyoti Saikia verfasserin aut Monikuntal Sarmah verfasserin aut In Journal of Clinical and Diagnostic Research JCDR Research and Publications Private Limited, 2009 17(2023), 1, Seite MC05-MC09 (DE-627)789478048 (DE-600)2775283-5 0973709X nnns volume:17 year:2023 number:1 pages:MC05-MC09 https://doi.org/10.7860/JCDR/2023/58318.17210 kostenfrei https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 kostenfrei https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf kostenfrei https://doaj.org/toc/2249-782X Journal toc kostenfrei https://doaj.org/toc/0973-709X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 17 2023 1 MC05-MC09 |
| allfieldsGer |
10.7860/JCDR/2023/58318.17210 doi (DE-627)DOAJ081274416 (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 DE-627 ger DE-627 rakwb eng MD Taher Ahmed Mazumder verfasserin aut Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss Medicine R Jyotirmoy Phookan verfasserin aut Nabajyoti Saikia verfasserin aut Monikuntal Sarmah verfasserin aut In Journal of Clinical and Diagnostic Research JCDR Research and Publications Private Limited, 2009 17(2023), 1, Seite MC05-MC09 (DE-627)789478048 (DE-600)2775283-5 0973709X nnns volume:17 year:2023 number:1 pages:MC05-MC09 https://doi.org/10.7860/JCDR/2023/58318.17210 kostenfrei https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 kostenfrei https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf kostenfrei https://doaj.org/toc/2249-782X Journal toc kostenfrei https://doaj.org/toc/0973-709X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 17 2023 1 MC05-MC09 |
| allfieldsSound |
10.7860/JCDR/2023/58318.17210 doi (DE-627)DOAJ081274416 (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 DE-627 ger DE-627 rakwb eng MD Taher Ahmed Mazumder verfasserin aut Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss Medicine R Jyotirmoy Phookan verfasserin aut Nabajyoti Saikia verfasserin aut Monikuntal Sarmah verfasserin aut In Journal of Clinical and Diagnostic Research JCDR Research and Publications Private Limited, 2009 17(2023), 1, Seite MC05-MC09 (DE-627)789478048 (DE-600)2775283-5 0973709X nnns volume:17 year:2023 number:1 pages:MC05-MC09 https://doi.org/10.7860/JCDR/2023/58318.17210 kostenfrei https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 kostenfrei https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf kostenfrei https://doaj.org/toc/2249-782X Journal toc kostenfrei https://doaj.org/toc/0973-709X Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 17 2023 1 MC05-MC09 |
| language |
English |
| source |
In Journal of Clinical and Diagnostic Research 17(2023), 1, Seite MC05-MC09 volume:17 year:2023 number:1 pages:MC05-MC09 |
| sourceStr |
In Journal of Clinical and Diagnostic Research 17(2023), 1, Seite MC05-MC09 volume:17 year:2023 number:1 pages:MC05-MC09 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss Medicine R |
| isfreeaccess_bool |
true |
| container_title |
Journal of Clinical and Diagnostic Research |
| authorswithroles_txt_mv |
MD Taher Ahmed Mazumder @@aut@@ Jyotirmoy Phookan @@aut@@ Nabajyoti Saikia @@aut@@ Monikuntal Sarmah @@aut@@ |
| publishDateDaySort_date |
2023-01-01T00:00:00Z |
| hierarchy_top_id |
789478048 |
| id |
DOAJ081274416 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ081274416</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230310211820.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230310s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7860/JCDR/2023/58318.17210</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ081274416</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">MD Taher Ahmed Mazumder</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">conductive hearing loss</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mixed hearing loss</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sensorineural hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jyotirmoy Phookan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nabajyoti Saikia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Monikuntal Sarmah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Clinical and Diagnostic Research</subfield><subfield code="d">JCDR Research and Publications Private Limited, 2009</subfield><subfield code="g">17(2023), 1, Seite MC05-MC09</subfield><subfield code="w">(DE-627)789478048</subfield><subfield code="w">(DE-600)2775283-5</subfield><subfield code="x">0973709X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:MC05-MC09</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.7860/JCDR/2023/58318.17210</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2249-782X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0973-709X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="h">MC05-MC09</subfield></datafield></record></collection>
|
| author |
MD Taher Ahmed Mazumder |
| spellingShingle |
MD Taher Ahmed Mazumder misc chemotherapy misc conductive hearing loss misc mixed hearing loss misc sensorineural hearing loss misc Medicine misc R Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study |
| authorStr |
MD Taher Ahmed Mazumder |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)789478048 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
0973709X |
| topic_title |
Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study chemotherapy conductive hearing loss mixed hearing loss sensorineural hearing loss |
| topic |
misc chemotherapy misc conductive hearing loss misc mixed hearing loss misc sensorineural hearing loss misc Medicine misc R |
| topic_unstemmed |
misc chemotherapy misc conductive hearing loss misc mixed hearing loss misc sensorineural hearing loss misc Medicine misc R |
| topic_browse |
misc chemotherapy misc conductive hearing loss misc mixed hearing loss misc sensorineural hearing loss misc Medicine misc R |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Journal of Clinical and Diagnostic Research |
| hierarchy_parent_id |
789478048 |
| hierarchy_top_title |
Journal of Clinical and Diagnostic Research |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)789478048 (DE-600)2775283-5 |
| title |
Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study |
| ctrlnum |
(DE-627)DOAJ081274416 (DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1 |
| title_full |
Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study |
| author_sort |
MD Taher Ahmed Mazumder |
| journal |
Journal of Clinical and Diagnostic Research |
| journalStr |
Journal of Clinical and Diagnostic Research |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2023 |
| contenttype_str_mv |
txt |
| author_browse |
MD Taher Ahmed Mazumder Jyotirmoy Phookan Nabajyoti Saikia Monikuntal Sarmah |
| container_volume |
17 |
| format_se |
Elektronische Aufsätze |
| author-letter |
MD Taher Ahmed Mazumder |
| doi_str_mv |
10.7860/JCDR/2023/58318.17210 |
| author2-role |
verfasserin |
| title_sort |
pure tone audiometry findings before and after radiotherapy in head and neck cancer patients: a hospital-based prospective interventional study |
| title_auth |
Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study |
| abstract |
Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. |
| abstractGer |
Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. |
| abstract_unstemmed |
Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
| container_issue |
1 |
| title_short |
Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study |
| url |
https://doi.org/10.7860/JCDR/2023/58318.17210 https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1 https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf https://doaj.org/toc/2249-782X https://doaj.org/toc/0973-709X |
| remote_bool |
true |
| author2 |
Jyotirmoy Phookan Nabajyoti Saikia Monikuntal Sarmah |
| author2Str |
Jyotirmoy Phookan Nabajyoti Saikia Monikuntal Sarmah |
| ppnlink |
789478048 |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.7860/JCDR/2023/58318.17210 |
| up_date |
2024-07-03T19:12:24.706Z |
| _version_ |
1803586313608232960 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ081274416</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230310211820.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230310s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.7860/JCDR/2023/58318.17210</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ081274416</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd83e41c6a684494fa56aaec58bdbdfa1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">MD Taher Ahmed Mazumder</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pure Tone Audiometry Findings before and after Radiotherapy in Head and Neck Cancer Patients: A Hospital-based Prospective Interventional Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction: Radiotherapy is still the major treatment modality for Head and Neck malignancies preferred by patients as well as surgeons. Temporal bone and brain stem are mostly included in the portals. So the middle ear, inner ear and brain stem may receive a significant radiation dose causing hearing loss. Aim: To study the effect of radiotherapy on hearing in patients with head and neck cancer. Materials and Methods: This study was a hospital based prospective interventional study, done in Assam Medical College and Hospital, Dibrugarh, Assam, India, from 1st July, 2020 to 30th June, 2021. A total of 33 patients with head and neck malignancies receiving radiotherapy as a mode of treatment attending Ear Nose Throat (ENT) Outpatient Department (OPD) and Department of Radiation Oncology were included. Pure Tone Audiometry was done for hearing assessment before and after radiotherapy. Microsoft excel version 2010 was used for recording the data. Results: A total of 66 ears (33 patients) have been evaluated. Out of 33 patients, 29 patients (87.88%) had decreased hearing in one/ both the ear after radiotherapy. Out of 29 patients, 19 patients (65.51%) had hearing loss less than 10 dB whereas, 10 patients (30.3%) had hearing loss <10 dB, which is considered as significant hearing loss. Among the 19 patients, 3 patients (15.78%) had hearing loss <10 dB on the same ear, i.e. on the same side of malignancy where the radiotherapy was given. Other 16 patients (48.48%) had hearing loss on both ear. Conclusion: Effect of radiotherapy with or without chemotherapy on hearing is a well known phenomenon. This study also established the fact of hearing loss in majority of patients receiving radiotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">conductive hearing loss</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">mixed hearing loss</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">sensorineural hearing loss</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jyotirmoy Phookan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Nabajyoti Saikia</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Monikuntal Sarmah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Clinical and Diagnostic Research</subfield><subfield code="d">JCDR Research and Publications Private Limited, 2009</subfield><subfield code="g">17(2023), 1, Seite MC05-MC09</subfield><subfield code="w">(DE-627)789478048</subfield><subfield code="w">(DE-600)2775283-5</subfield><subfield code="x">0973709X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:MC05-MC09</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.7860/JCDR/2023/58318.17210</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d83e41c6a684494fa56aaec58bdbdfa1</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.jcdr.net/articles/PDF/17210/58318_CE(Vi)_F(IS)_PF1(AKA_KM)_PFA(NC_KM)_PN(KM).pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2249-782X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/0973-709X</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="h">MC05-MC09</subfield></datafield></record></collection>
|
| score |
7.399205 |